Rain Therapeutics: Funding, Investors & Team (Oct 2026)
Rain Therapeutics develops targeted therapies for patients with cancer. We begin by identifing cancers with a single, and clear, oncogenic driver and evaluating sub-populations of cancer populations with an unmet need, where standards of care are ineffective. Our global scientific and thought-leader network drives our asset and technology identification to match these cancers with small molecule therapeutics targeted at treating specific cancer mutations.
Rain Therapeutics has raised $63.0M across 1 funding round on record, the most recent an undisclosed round of $63.0M announced in Sep 2020.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Rain Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Rain Therapeutics Funding Rounds
Rain Therapeutics Founders and Leadership Team
Contact details for the Rain Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Rain Therapeutics Funding Compared to Other Biotechnology Startups
Rain Therapeutics' latest round of $63.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Rain Therapeutics in Biotechnology and Fremont
Companies Similar to Rain Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Rain Therapeutics Funding FAQs
What does Rain Therapeutics do?
Rain Therapeutics develops targeted therapies for patients with cancer. We begin by identifing cancers with a single, and clear, oncogenic driver and evaluating sub-populations of cancer populations with an unmet need, where standards of care are ineffective. Our global scientific and thought-leader network drives our asset and technology identification to match these cancers with small molecule therapeutics targeted at treating specific cancer mutations.
How much funding has Rain Therapeutics raised?
Rain Therapeutics has raised $63.0M across 1 round on record. The most recent is an undisclosed round of $63.0M announced in Sep 2020.
When did Rain Therapeutics last raise funding?
Rain Therapeutics' most recent funding round on record is an undisclosed round of $63.0M, announced in Sep 2020.
Who is the CEO of Rain Therapeutics?
Avanish Vellanki is listed as CEO at Rain Therapeutics.
Where is Rain Therapeutics headquartered?
Rain Therapeutics is based in Fremont, California, United States.
How many employees does Rain Therapeutics have?
Rain Therapeutics is in the 11-50 employee band.
How does Rain Therapeutics' funding compare to other Biotechnology startups?
Rain Therapeutics' latest round of $63.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Rain Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Rain Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.